{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:55:42Z","timestamp":1780574142223,"version":"3.54.1"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens and Disease"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1093\/femspd\/ftw016","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T01:03:49Z","timestamp":1459904629000},"page":"ftw016","source":"Crossref","is-referenced-by-count":21,"title":["Towards new TB vaccines: What are the challenges?"],"prefix":"10.1093","volume":"74","author":[{"given":"Hazel M.","family":"Dockrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"key":"2016040518034187000_74.4.ftw016.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303657"},{"key":"2016040518034187000_74.4.ftw016.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.07.051"},{"key":"2016040518034187000_74.4.ftw016.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.17.2086"},{"key":"2016040518034187000_74.4.ftw016.4","doi-asserted-by":"publisher","DOI":"10.1038\/nature09247"},{"key":"2016040518034187000_74.4.ftw016.5","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00721-14"},{"key":"2016040518034187000_74.4.ftw016.6","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.9.4.901-907.2002"},{"key":"2016040518034187000_74.4.ftw016.7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv447"},{"key":"2016040518034187000_74.4.ftw016.8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis499"},{"key":"2016040518034187000_74.4.ftw016.9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Gu\u00e9rin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"2016040518034187000_74.4.ftw016.10","doi-asserted-by":"publisher","DOI":"10.1038\/31159"},{"key":"2016040518034187000_74.4.ftw016.11","doi-asserted-by":"publisher","DOI":"10.1038\/ng.590"},{"key":"2016040518034187000_74.4.ftw016.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.113"},{"key":"2016040518034187000_74.4.ftw016.13","doi-asserted-by":"crossref","first-page":"e00960","DOI":"10.1128\/mBio.00960-13","article-title":"Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition","volume":"5","author":"Copin","year":"2014","journal-title":"MBio"},{"key":"2016040518034187000_74.4.ftw016.14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clinbiochem.2015.08.013","article-title":"Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa","volume":"49","author":"Corstjens","year":"2016","journal-title":"Clin Biochem"},{"key":"2016040518034187000_74.4.ftw016.15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(15)00151-8","article-title":"Tuberculosis","volume":"387","author":"Dheda","year":"2016","journal-title":"Lancet"},{"key":"2016040518034187000_74.4.ftw016.16","doi-asserted-by":"publisher","DOI":"10.4161\/hv.25280"},{"key":"2016040518034187000_74.4.ftw016.17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tube.2015.02.036","article-title":"Innovative clinical trial designs to rationalize TB vaccine development","volume":"95","author":"Ellis","year":"2015","journal-title":"Tuberculosis"},{"key":"2016040518034187000_74.4.ftw016.18","doi-asserted-by":"crossref","first-page":"e01187","DOI":"10.1128\/mBio.01187-15","article-title":"Epigenetics and proteomics join transcriptomics in the quest for tuberculosis biomarkers","volume":"6","author":"Esterhuyse","year":"2015","journal-title":"Mbio"},{"key":"2016040518034187000_74.4.ftw016.19","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00427-13"},{"key":"2016040518034187000_74.4.ftw016.20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151468"},{"key":"2016040518034187000_74.4.ftw016.21","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.vaccine.2015.05.036","article-title":"The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: a randomized controlled trial","volume":"33","author":"Geldenhuys","year":"2015","journal-title":"Vaccine"},{"key":"2016040518034187000_74.4.ftw016.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001843"},{"key":"2016040518034187000_74.4.ftw016.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.053"},{"key":"2016040518034187000_74.4.ftw016.24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/MMBR.00021-14","article-title":"Tuberculosis vaccines and prevention of infection","volume":"78","author":"Hawn","year":"2014","journal-title":"Microbiol Mol Bio R"},{"key":"2016040518034187000_74.4.ftw016.25","doi-asserted-by":"crossref","first-page":"e0136500","DOI":"10.1371\/journal.pone.0136500","article-title":"The efficacy of the BCG vaccine against newly emerging clinical strains of Mycobacterium tuberculosis","volume":"10","author":"Henao-Tamayo","year":"2015","journal-title":"PLoS One"},{"key":"2016040518034187000_74.4.ftw016.26","doi-asserted-by":"publisher","DOI":"10.1086\/344359"},{"key":"2016040518034187000_74.4.ftw016.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001538"},{"key":"2016040518034187000_74.4.ftw016.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201003-0334OC"},{"key":"2016040518034187000_74.4.ftw016.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.09.001"},{"key":"2016040518034187000_74.4.ftw016.30","doi-asserted-by":"publisher","DOI":"10.1086\/315766"},{"key":"2016040518034187000_74.4.ftw016.31","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.11.6401-6407.2004"},{"key":"2016040518034187000_74.4.ftw016.32","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12270"},{"key":"2016040518034187000_74.4.ftw016.33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(15)00458-0","article-title":"Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis","volume":"3","author":"Kendall","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2016040518034187000_74.4.ftw016.34","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ579"},{"key":"2016040518034187000_74.4.ftw016.35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1404386111"},{"key":"2016040518034187000_74.4.ftw016.36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00281-015-0538-9","article-title":"Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies","volume":"38","author":"Kramnik","year":"2016","journal-title":"Semin Immunopathol"},{"key":"2016040518034187000_74.4.ftw016.37","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"key":"2016040518034187000_74.4.ftw016.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2013.11.003"},{"key":"2016040518034187000_74.4.ftw016.39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit790"},{"key":"2016040518034187000_74.4.ftw016.40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tube.2013.04.007","article-title":"Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)","volume":"93","author":"Marsay","year":"2013","journal-title":"Tuberculosis"},{"key":"2016040518034187000_74.4.ftw016.41","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1016\/j.vaccine.2015.08.033","article-title":"Prospects in Mycobacterium bovis Bacille Calmette et Gu\u00e9rin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?","volume":"33","author":"Moliva","year":"2015","journal-title":"Vaccine"},{"key":"2016040518034187000_74.4.ftw016.42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S2213-2600(15)00037-5","article-title":"Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial","volume":"3","author":"Ndiaye","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2016040518034187000_74.4.ftw016.43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089612"},{"key":"2016040518034187000_74.4.ftw016.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.054"},{"key":"2016040518034187000_74.4.ftw016.45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401103"},{"key":"2016040518034187000_74.4.ftw016.46","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00067-09"},{"key":"2016040518034187000_74.4.ftw016.47","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2015.05.088","article-title":"Safety and immunogenicity of candidate vaccine M72\/AS01E in adolescents in a TB endemic setting","volume":"33","author":"Penn-Nicholson","year":"2015","journal-title":"Vaccine"},{"key":"2016040518034187000_74.4.ftw016.48","unstructured":"Public Health England. Tuberculosis in England. 2015 Report. 2015. https:\/\/www.gov.uk\/government\/publications\/tuberculosis-tb-in-the-uk (12 November 2015, date last accessed)."},{"key":"2016040518034187000_74.4.ftw016.49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114602"},{"key":"2016040518034187000_74.4.ftw016.50","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4643"},{"key":"2016040518034187000_74.4.ftw016.51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tube.2013.08.010","article-title":"Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis","volume":"94","author":"Shanley","year":"2014","journal-title":"Tuberculosis"},{"key":"2016040518034187000_74.4.ftw016.52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00098"},{"key":"2016040518034187000_74.4.ftw016.53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007972"},{"key":"2016040518034187000_74.4.ftw016.54","doi-asserted-by":"crossref","first-page":"e0138042","DOI":"10.1371\/journal.pone.0138042","article-title":"Intracellular cytokine staining and flow cytometry: considerations for application in clinical trials of novel tuberculosis vaccines","volume":"10","author":"Smith","year":"2015","journal-title":"PLoS One"},{"key":"2016040518034187000_74.4.ftw016.55","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S2213-2600(15)00435-X","article-title":"Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial","volume":"3","author":"Spertini","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2016040518034187000_74.4.ftw016.56","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung D"},{"key":"2016040518034187000_74.4.ftw016.57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087340"},{"key":"2016040518034187000_74.4.ftw016.58","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1016\/j.vaccine.2015.03.070","article-title":"A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants","volume":"33","author":"Tameris","year":"2015","journal-title":"Vaccine"},{"key":"2016040518034187000_74.4.ftw016.59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60177-4"},{"key":"2016040518034187000_74.4.ftw016.60","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12212"},{"key":"2016040518034187000_74.4.ftw016.61","unstructured":"World Health Organisation. Tuberculosis and air travel. Guidelines for prevention and control. 2008. www.who.int\/entity\/tb\/publications\/tb-airtravel-guidance\/en\/ (13 October 2015, date last accessed)."},{"key":"2016040518034187000_74.4.ftw016.62","unstructured":"World Health Organisation. Global Tuberculosis Report. 2015a. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ (13 October 2015, date last accessed)."},{"key":"2016040518034187000_74.4.ftw016.63","unstructured":"World Health Organisation. End Tb strategy. 2015b. http:\/\/www.who.int\/tb\/End_TB_brochure.pdf?ua=1 (13 October 2015, date last accessed)."},{"key":"2016040518034187000_74.4.ftw016.64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1473-3099(15)00499-5","article-title":"The transmission of Mycobacterium tuberculosis in high burden settings","volume":"16","author":"Yates","year":"2016","journal-title":"Lancet Infect Dis"}],"container-title":["Pathogens and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/74\/4\/ftw016\/10751120\/ftw016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:43:32Z","timestamp":1655441012000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1093\/femspd\/ftw016"}},"subtitle":[],"editor":[{"given":"Patrick","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,5]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1093\/femspd\/ftw016"],"URL":"https:\/\/doi.org\/10.1093\/femspd\/ftw016","relation":{},"ISSN":["2049-632X","2049-632X"],"issn-type":[{"value":"2049-632X","type":"print"},{"value":"2049-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,9]]}}}